{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T16:20:07Z","timestamp":1787761207975,"version":"build-2784847793"},"reference-count":45,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1124\/jpet.119.258632","type":"journal-article","created":{"date-parts":[[2019,9,18]],"date-time":"2019-09-18T20:34:11Z","timestamp":1568838851000},"page":"590-601","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Functional Interaction between Pregnane X Receptor and Yes-Associated Protein in Xenobiotic-Dependent Liver Hypertrophy and Drug Metabolism"],"prefix":"10.1016","volume":"371","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6580-3734","authenticated-orcid":false,"given":"Taiki","family":"Abe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryota","family":"Shizu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takamitsu","family":"Sasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuomi","family":"Hosaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susumu","family":"Kodama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Matsuzawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kouichi","family":"Yoshinari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.119.258632_bib1","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1093\/toxsci\/kfy149","article-title":"Role of YAP activation in nuclear receptor CAR-mediated proliferation of mouse hepatocytes","volume":"165","author":"Abe","year":"2018","journal-title":"Toxicol Sci"},{"key":"10.1124\/jpet.119.258632_bib2","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1007\/s00204-016-1888-3","article-title":"Activation of nuclear receptor CAR by an environmental pollutant perfluorooctanoic acid","volume":"91","author":"Abe","year":"2017","journal-title":"Arch Toxicol"},{"key":"10.1124\/jpet.119.258632_bib3","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.celrep.2014.08.046","article-title":"Hippo signaling influences HNF4A and FOXA2 enhancer switching during hepatocyte differentiation","volume":"9","author":"Alder","year":"2014","journal-title":"Cell Rep"},{"key":"10.1124\/jpet.119.258632_bib4","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1002\/hep.22475","article-title":"C-Myc and its target FoxM1 are critical downstream effectors of constitutive androstane receptor (CAR) mediated direct liver hyperplasia","volume":"48","author":"Blanco-Bose","year":"2008","journal-title":"Hepatology"},{"key":"10.1124\/jpet.119.258632_bib5","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1038\/bjc.1978.62","article-title":"Long-term effects of phenobarbitone-Na on male Fischer rats","volume":"37","author":"Butler","year":"1978","journal-title":"Br J Cancer"},{"key":"10.1124\/jpet.119.258632_bib6","doi-asserted-by":"crossref","first-page":"28383","DOI":"10.1038\/srep28383","article-title":"MDCK cells expressing constitutively active Yes-associated protein (YAP) undergo apical extrusion depending on neighboring cell status","volume":"6","author":"Chiba","year":"2016","journal-title":"Sci Rep"},{"key":"10.1124\/jpet.119.258632_bib7","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1038\/ncb2634","article-title":"Hippo-YAP and mTOR pathways collaborate to regulate organ size","volume":"14","author":"Csibi","year":"2012","journal-title":"Nat Cell Biol"},{"key":"10.1124\/jpet.119.258632_bib8","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1016\/j.celrep.2015.02.027","article-title":"YAP inhibition restores hepatocyte differentiation in advanced HCC, leading to tumor regression","volume":"10","author":"Fitamant","year":"2015","journal-title":"Cell Rep"},{"key":"10.1124\/jpet.119.258632_bib9","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.3892\/ijo.2015.2877","article-title":"YAP\/TAZ for cancer therapy: opportunities and challenges (review)","volume":"46","author":"Guo","year":"2015","journal-title":"Int J Oncol"},{"key":"10.1124\/jpet.119.258632_bib10","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1177\/0192623312448935","article-title":"Liver hypertrophy: a review of adaptive (adverse and non-adverse) changes\u2014conclusions from the 3rd International ESTP Expert Workshop","volume":"40","author":"Hall","year":"2012","journal-title":"Toxicol Pathol"},{"key":"10.1124\/jpet.119.258632_bib11","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1038\/nrc3458","article-title":"The Hippo pathway and human cancer","volume":"13","author":"Harvey","year":"2013","journal-title":"Nat Rev Cancer"},{"key":"10.1124\/jpet.119.258632_bib12","doi-asserted-by":"crossref","first-page":"81","DOI":"10.2174\/187569209788654005","article-title":"Activation of CAR and PXR by dietary, environmental and occupational chemicals alters drug metabolism, intermediary metabolism, and cell proliferation","volume":"7","author":"Hernandez","year":"2009","journal-title":"Curr Pharmacogenomics Person Med"},{"key":"10.1124\/jpet.119.258632_bib13","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1002\/hep.30131","article-title":"Pregnane X receptor regulates liver size and liver cell fate by yes-associated protein activation in mice","volume":"69","author":"Jiang","year":"2019","journal-title":"Hepatology"},{"key":"10.1124\/jpet.119.258632_bib14","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/j.febslet.2010.01.017","article-title":"mTOR regulation of autophagy","volume":"584","author":"Jung","year":"2010","journal-title":"FEBS Lett"},{"key":"10.1124\/jpet.119.258632_bib15","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1210\/mend.14.11.0547","article-title":"Estrogen activation of the nuclear orphan receptor CAR (constitutive active receptor) in induction of the mouse Cyp2b10 gene","volume":"14","author":"Kawamoto","year":"2000","journal-title":"Mol Endocrinol"},{"key":"10.1124\/jpet.119.258632_bib16","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1210\/er.2001-0038","article-title":"The nuclear pregnane X receptor: a key regulator of xenobiotic metabolism","volume":"23","author":"Kliewer","year":"2002","journal-title":"Endocr Rev"},{"key":"10.1124\/jpet.119.258632_bib17","doi-asserted-by":"crossref","first-page":"7931","DOI":"10.1128\/MCB.24.18.7931-7940.2004","article-title":"Nuclear receptors CAR and PXR cross talk with FOXO1 to regulate genes that encode drug-metabolizing and gluconeogenic enzymes","volume":"24","author":"Kodama","year":"2004","journal-title":"Mol Cell Biol"},{"key":"10.1124\/jpet.119.258632_bib18","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1083\/jcb.200412022","article-title":"Impairment of starvation-induced and constitutive autophagy in Atg7-deficient mice","volume":"169","author":"Komatsu","year":"2005","journal-title":"J Cell Biol"},{"key":"10.1124\/jpet.119.258632_bib19","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1146\/annurev.pharmtox.47.120505.105359","article-title":"mTOR pathway as a target in tissue hypertrophy","volume":"47","author":"Lee","year":"2007","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1124\/jpet.119.258632_bib20","doi-asserted-by":"crossref","first-page":"11961","DOI":"10.1038\/ncomms11961","article-title":"LATS-YAP\/TAZ controls lineage specification by regulating TGF\u03b2 signaling and Hnf4\u03b1 expression during liver development","volume":"7","author":"Lee","year":"2016","journal-title":"Nat Commun"},{"key":"10.1124\/jpet.119.258632_bib21","doi-asserted-by":"crossref","first-page":"pe4","DOI":"10.1126\/scisignal.2003813","article-title":"The Hippo size control pathway\u2014ever expanding","volume":"6","author":"Lin","year":"2013","journal-title":"Sci Signal"},{"key":"10.1124\/jpet.119.258632_bib22","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1101\/gad.192856.112","article-title":"Genetic and pharmacological disruption of the TEAD-YAP complex suppresses the oncogenic activity of YAP","volume":"26","author":"Liu-Chittenden","year":"2012","journal-title":"Genes Dev"},{"key":"10.1124\/jpet.119.258632_bib23","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1177\/0192623310373778","article-title":"Hepatic enzyme induction: histopathology","volume":"38","author":"Maronpot","year":"2010","journal-title":"Toxicol Pathol"},{"key":"10.1124\/jpet.119.258632_bib24","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1080\/00498250210128675","article-title":"Cytochrome P450 expression in human hepatocytes and hepatoma cell lines: molecular mechanisms that determine lower expression in cultured cells","volume":"32","author":"Rodr\u00edguez-Antona","year":"2002","journal-title":"Xenobiotica"},{"key":"10.1124\/jpet.119.258632_bib25","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0091-679X(08)61797-5","article-title":"Preparation of isolated rat liver cells","volume":"13","author":"Seglen","year":"1976","journal-title":"Methods Cell Biol"},{"key":"10.1124\/jpet.119.258632_bib26","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1042\/BJ20150734","article-title":"PXR stimulates growth factor-mediated hepatocyte proliferation by cross-talk with the FOXO transcription factor","volume":"473","author":"Shizu","year":"2016","journal-title":"Biochem J"},{"key":"10.1124\/jpet.119.258632_bib27","doi-asserted-by":"crossref","first-page":"e61802","DOI":"10.1371\/journal.pone.0061802","article-title":"Xenobiotic-induced hepatocyte proliferation associated with constitutive active\/androstane receptor (CAR) or peroxisome proliferator-activated receptor \u03b1 (PPAR\u03b1) is enhanced by pregnane X receptor (PXR) activation in mice","volume":"8","author":"Shizu","year":"2013","journal-title":"PLoS One"},{"key":"10.1124\/jpet.119.258632_bib28","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1073\/pnas.0911409107","article-title":"Mammalian Mst1 and Mst2 kinases play essential roles in organ size control and tumor suppression","volume":"107","author":"Song","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/jpet.119.258632_bib29","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1016\/j.humpath.2008.04.012","article-title":"Expression of Yes-associated protein in common solid tumors","volume":"39","author":"Steinhardt","year":"2008","journal-title":"Hum Pathol"},{"key":"10.1124\/jpet.119.258632_bib30","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1016\/j.addr.2010.08.006","article-title":"Regulation of drug-metabolizing enzymes by xenobiotic receptors: PXR and CAR","volume":"62","author":"Tolson","year":"2010","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1124\/jpet.119.258632_bib31","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1124\/mol.108.050575","article-title":"Unveiling a new essential cis element for the transactivation of the CYP3A4 gene by xenobiotics","volume":"75","author":"Toriyabe","year":"2009","journal-title":"Mol Pharmacol"},{"key":"10.1124\/jpet.119.258632_bib32","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1038\/ncb2615","article-title":"YAP mediates crosstalk between the Hippo and PI3K-TOR pathways by suppressing PTEN via miR-29","volume":"14","author":"Tumaneng","year":"2012","journal-title":"Nat Cell Biol"},{"key":"10.1124\/jpet.119.258632_bib33","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1111\/j.1349-7006.2010.01511.x","article-title":"Overexpression of yes-associated protein contributes to progression and poor prognosis of non-small-cell lung cancer","volume":"101","author":"Wang","year":"2010","journal-title":"Cancer Sci"},{"key":"10.1124\/jpet.119.258632_bib34","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1038\/35038112","article-title":"The nuclear receptor CAR mediates specific xenobiotic induction of drug metabolism","volume":"407","author":"Wei","year":"2000","journal-title":"Nature"},{"key":"10.1124\/jpet.119.258632_bib35","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0940-2993(96)80041-8","article-title":"Epigenetic carcinogens: evaluation and risk assessment","volume":"48","author":"Williams","year":"1996","journal-title":"Exp Toxicol Pathol"},{"key":"10.1124\/jpet.119.258632_bib36","doi-asserted-by":"crossref","first-page":"4576","DOI":"10.1002\/cncr.24495","article-title":"Yes-associated protein is an independent prognostic marker in hepatocellular carcinoma","volume":"115","author":"Xu","year":"2009","journal-title":"Cancer"},{"key":"10.1124\/jpet.119.258632_bib37","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1242\/jcs.113431","article-title":"N-terminal truncation of Lats1 causes abnormal cell growth control and chromosomal instability","volume":"126","author":"Yabuta","year":"2013","journal-title":"J Cell Sci"},{"key":"10.1124\/jpet.119.258632_bib38","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.toxlet.2011.11.003","article-title":"Constitutive androstane receptor transactivates the hepatic expression of mouse Dhcr24 and human DHCR24 encoding a cholesterogenic enzyme 24-dehydrocholesterol reductase","volume":"208","author":"Yoshinari","year":"2012","journal-title":"Toxicol Lett"},{"key":"10.1124\/jpet.119.258632_bib39","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1007\/s11095-006-0071-6","article-title":"Hepatic CYP3A expression is attenuated in obese mice fed a high-fat diet","volume":"23","author":"Yoshinari","year":"2006","journal-title":"Pharm Res"},{"key":"10.1124\/jpet.119.258632_bib40","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.bcp.2009.08.008","article-title":"Constitutive androstane receptor transcriptionally activates human CYP1A1 and CYP1A2 genes through a common regulatory element in the 5\u2032-flanking region","volume":"79","author":"Yoshinari","year":"2010","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/jpet.119.258632_bib41","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1016\/j.cell.2006.05.030","article-title":"Identification and validation of oncogenes in liver cancer using an integrative oncogenomic approach","volume":"125","author":"Zender","year":"2006","journal-title":"Cell"},{"key":"10.1124\/jpet.119.258632_bib42","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/cr.2014.10","article-title":"VGLL4 functions as a new tumor suppressor in lung cancer by negatively regulating the YAP-TEAD transcriptional complex","volume":"24","author":"Zhang","year":"2014","journal-title":"Cell Res"},{"key":"10.1124\/jpet.119.258632_bib43","doi-asserted-by":"crossref","first-page":"2810","DOI":"10.1038\/onc.2011.8","article-title":"The Hippo pathway transcriptional co-activator, YAP, is an ovarian cancer oncogene","volume":"30","author":"Zhang","year":"2011","journal-title":"Oncogene"},{"key":"10.1124\/jpet.119.258632_bib44","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1101\/gad.1602907","article-title":"Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control","volume":"21","author":"Zhao","year":"2007","journal-title":"Genes Dev"},{"key":"10.1124\/jpet.119.258632_bib45","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.ccr.2009.09.026","article-title":"Mst1 and Mst2 maintain hepatocyte quiescence and suppress hepatocellular carcinoma development through inactivation of the Yap1 oncogene","volume":"16","author":"Zhou","year":"2009","journal-title":"Cancer Cell"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002235652426849X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002235652426849X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.119.258632","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T13:57:31Z","timestamp":1739973451000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002235652426849X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":45,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["S002235652426849X"],"URL":"https:\/\/doi.org\/10.1124\/jpet.119.258632","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Functional Interaction between Pregnane X Receptor and Yes-Associated Protein in Xenobiotic-Dependent Liver Hypertrophy and Drug Metabolism","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.119.258632","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}